Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

"Patients enrolled in Part A will receive treatment daily x 5 on weeks 1, 3, and 5 of an 8 week cycle.~Patients enrolled in Part B will receive treatment daily x 5 on weeks 1, and 3 of a 6 week cycle"

Cycle 1 Day 1 and Cycle 1 Day 29

slides will be blocked for 15 minutes in 20% normal goat serum and then incubated in primary antibody

Starting dose of 50μg/kg/day as an IV push